545 related articles for article (PubMed ID: 22267310)
1. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.
Guihard P; Danger Y; Brounais B; David E; Brion R; Delecrin J; Richards CD; Chevalier S; Rédini F; Heymann D; Gascan H; Blanchard F
Stem Cells; 2012 Apr; 30(4):762-72. PubMed ID: 22267310
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells.
Song HY; Jeon ES; Kim JI; Jung JS; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1238-51. PubMed ID: 17226768
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury.
Guihard P; Boutet MA; Brounais-Le Royer B; Gamblin AL; Amiaud J; Renaud A; Berreur M; Rédini F; Heymann D; Layrolle P; Blanchard F
Am J Pathol; 2015 Mar; 185(3):765-75. PubMed ID: 25559270
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
5. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
7. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
8. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity.
Nawa K; Ikeno H; Matsuhashi N; Ogasawara T; Otsuka E
Differentiation; 2013; 86(1-2):65-74. PubMed ID: 23995451
[TBL] [Abstract][Full Text] [Related]
9. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells.
Lee SS; Sharma AR; Choi BS; Jung JS; Chang JD; Park S; Salvati EA; Purdue EP; Song DK; Nam JS
Biomaterials; 2012 Jun; 33(17):4251-63. PubMed ID: 22436801
[TBL] [Abstract][Full Text] [Related]
10. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation.
Nicolaidou V; Wong MM; Redpath AN; Ersek A; Baban DF; Williams LM; Cope AP; Horwood NJ
PLoS One; 2012; 7(7):e39871. PubMed ID: 22802946
[TBL] [Abstract][Full Text] [Related]
11. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
12. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor contributes to hepatocyte-like differentiation of human bone marrow mesenchymal stem cells.
Lysy PA; Smets F; Najimi M; Sokal EM
Differentiation; 2008 Dec; 76(10):1057-67. PubMed ID: 18557762
[TBL] [Abstract][Full Text] [Related]
14. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
15. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.
Itoh S; Udagawa N; Takahashi N; Yoshitake F; Narita H; Ebisu S; Ishihara K
Bone; 2006 Sep; 39(3):505-12. PubMed ID: 16679075
[TBL] [Abstract][Full Text] [Related]
16. IL-3 promotes osteoblast differentiation and bone formation in human mesenchymal stem cells.
Barhanpurkar AP; Gupta N; Srivastava RK; Tomar GB; Naik SP; Joshi SR; Pote ST; Mishra GC; Wani MR
Biochem Biophys Res Commun; 2012 Feb; 418(4):669-75. PubMed ID: 22293197
[TBL] [Abstract][Full Text] [Related]
17. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.
Gharibi B; Abraham AA; Ham J; Evans BA
J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734
[TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
19. The role of noggin in human mesenchymal stem cell differentiation.
Rifas L
J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
[TBL] [Abstract][Full Text] [Related]
20. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]